SWOT Analysis for Bliss GVS Pharma Ltd.

Add SWOT widget to your site/app

MACD Crossover Above Signal Line
High DVM Mid and Small Caps (subscription)
Benjamin Graham Value Screen
Price crossing above SMA20 today, and greater than SMA5
Companies with 10% increase in share price over three months, with rising net profit growth
Undervalued Growth Stocks
Strong Momentum: Price above short, medium and long term moving averages
Consistent Highest Return Stocks over Five Years
Relative Outperformance versus Industry over 1 Month
High DVM Midcap Stocks (MarketCap 1000-10,000)
Companies with high TTM EPS Growth
Best Bargains Screener: Above line growth, Below line valuations
Stocks whose current price is 20% higher than week low, and more than previous close
PEG lower than Industry PEG
Stocks gaining versus previous close, open price and RSI
New 52 week high today
High Momentum Scores (Technical Scores greater than 50)
Results in the last two days with YoY and QoQ Net Profit Growth
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Negative to Positive growth in Sales and Profit with Strong Price momentum
MACD crossed above signal line previous end of day
Biggest Price Gainers from Open
New 52 Week High
Stocks near 52 Week High with Significant Volumes
Insiders bought stocks
Stocks Outperforming their Industry Price Change in the Quarter

MACD Crossover Above Signal Line

High DVM Mid and Small Caps (subscription)

Benjamin Graham Value Screen

Price crossing above SMA20 today, and greater than SMA5

Companies with 10% increase in share price over three months, with rising net profit growth

Undervalued Growth Stocks

Strong Momentum: Price above short, medium and long term moving averages

Consistent Highest Return Stocks over Five Years

Relative Outperformance versus Industry over 1 Month

High DVM Midcap Stocks (MarketCap 1000-10,000)

Companies with high TTM EPS Growth

Best Bargains Screener: Above line growth, Below line valuations

Stocks whose current price is 20% higher than week low, and more than previous close

PEG lower than Industry PEG

Stocks gaining versus previous close, open price and RSI

New 52 week high today

High Momentum Scores (Technical Scores greater than 50)

Results in the last two days with YoY and QoQ Net Profit Growth

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Negative to Positive growth in Sales and Profit with Strong Price momentum

MACD crossed above signal line previous end of day

Biggest Price Gainers from Open

New 52 Week High

Stocks near 52 Week High with Significant Volumes

Insiders bought stocks

Stocks Outperforming their Industry Price Change in the Quarter

Companies with growing costs YoY for long term projects
Decline in Quarterly Net Profit (YoY)
Increasing Trend in Non-Core Income
Top Losers

Companies with growing costs YoY for long term projects

Decline in Quarterly Net Profit (YoY)

Increasing Trend in Non-Core Income

Top Losers

Mutual Funds Increased Shareholding over the Past Two Months

Mutual Funds Increased Shareholding over the Past Two Months

Promoters increasing shareholding QoQ
Strong Performers - High DVM Stocks
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Promoters increasing shareholding QoQ

Strong Performers - High DVM Stocks

Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Bliss GVS Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Bliss GVS Pharma Ltd. has 35 Strengths, 4 Weaknesses, 1 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential